Disease & disorder

muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3

MONDO:0009667

An autosomal recessive muscular dystrophy caused by mutations in the POMGNT1 gene. It is associated with characteristic brain and eye malformations, profound mental retardation, and death usually in the first years of life.

Outbreak surveillance

Global reported events

Explore recent public health notices potentially related to muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3. Results are keyword matches, not yet verified disease-to-outbreak relationships.

View muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 on the outbreak map →
Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms4
Advertisement

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.